NCT02741674

Brief Summary

The main goal of this research project is to conduct a comparative effectiveness research study involving existing data in the PCORnet Common Data Model to provide accurate estimates of the 1-, 3-, and 5-year benefits and risks of the three most common bariatric procedures - Roux-en-y gastric bypass, adjustable gastric banding, and sleeve gastrectomy - with a focus on outcomes that are important to adults and adolescents with severe obesity: 1) changes in weight, 2) rates of remission and relapse of diabetes, and 3) major adverse events.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65,093

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2016

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 11, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 18, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2018

Completed
Last Updated

December 21, 2023

Status Verified

December 1, 2023

Enrollment Period

2.2 years

First QC Date

April 11, 2016

Last Update Submit

December 14, 2023

Conditions

Keywords

Observational StudyComparative Effectiveness Research

Outcome Measures

Primary Outcomes (3)

  • Body Mass Index (BMI)

    Change in Body Mass Index (BMI)

    1, 3, and 5 years after primary bariatric procedure

  • Diabetes Remission

    Remission of diabetes after primary bariatric procedure. Defined as individual no longer using any diabetes medication for at least 3 months and hemoglobin A1c (HbA1c) \<6.5% after 3 months off of diabetes medication.

    1, 3, and 5 years after primary bariatric procedure

  • Reoperation/Rehospitalization Rate

    Reoperation: Any additional bariatric procedure and other procedures related to device removals, gastric revisions, abdominal or incisional hernia repair, laparoscopy or laparotomy, and percutaneous endoscopic gastrostomy tube placements. Rehospitalization: Any inpatient hospitalization following surgery that is not associated with a delivery, miscarriage, or abortion procedure.

    1, 3, and 5 years after primary bariatric procedure

Secondary Outcomes (5)

  • Weight regain

    3 and 5 years after primary bariatric procedure

  • Diabetes relapse

    1, 3 and 5 years after primary bariatric procedure

  • Change in hemoglobin A1C (HbA1c)

    1, 3, and 5 years after primary bariatric procedure

  • Mortality Rate

    1, 3, and 5 years after primary bariatric procedure

  • Composite Adverse Event

    30-days after primary bariatric procedure

Study Arms (3)

Roux-en-y gastric bypass (RYGB)

1. Adults and children ages 12 ≤79 years at time of surgery 2. Had a primary (not revision) Roux-en-y gastric bypass from years 2005-2015 (based on ICD-9-CM, CPT-4, and HCPCS codes) 3. Have a Body Mass Index (BMI) measurement in the year prior to surgery that is ≥35 kg/m2 for adults and adolescents

Procedure: Roux-en-y gastric bypass (RYGB) - historical

Adjustable gastric banding (AGB)

1. Adults and children age 12 ≤79 years at time of surgery 2. Had a primary (not revision) adjustable gastric banding procedure from years 2005-2015 (based on ICD-9-CM, CPT-4, and HCPCS codes) 3. Have a Body Mass Index (BMI) measurement in the year prior to surgery that is ≥35 kg/m2 for adults and adolescents

Procedure: Adjustable gastric banding (AGB) - historical

Sleeve gastrectomy (SG)

1. Adults and children age 12 ≤79 years at time of surgery 2. Had a primary (not revision) sleeve gastrectomy from years 2005-2015 (based on ICD-9-CM, CPT-4, and HCPCS codes) 3. Have a Body Mass Index (BMI) measurement in the year prior to surgery that is ≥35 kg/m2 for adults and adolescents

Procedure: Sleeve gastrectomy (SG) - historical

Interventions

Participant has had RYGB, as identified using existing data

Roux-en-y gastric bypass (RYGB)

Participant has had AGB, as identified using existing data

Adjustable gastric banding (AGB)

Participant has had SG, as identified using existing data

Sleeve gastrectomy (SG)

Eligibility Criteria

Age12 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population are children and adults (aged 12 through 79 years of age) who have undergone one of the three most common bariatric procedures performed in the United Sates - Roux-en-y gastric bypass, adjustable gastric banding, and sleeve gastrectomy. The population will be identified using participating sites' PCORnet Common Data Model (CDM).

You may qualify if:

  • Adults and children ages 12 ≤79 years at time of surgery
  • Had a primary (not revision) bariatric procedure from years 2005-2015 of one of three types:
  • Roux-en-y gastric bypass (RYGB)
  • Adjustable gastric banding (AGB)
  • Sleeve gastrectomy (SG)
  • Have a Body Mass Index (BMI) measurement in the year prior to surgery that is ≥35 kg/m2

You may not qualify if:

  • First bariatric procedure during the study period is a revision procedure, a vertical banded gastroplasty procedure or Biliopancreatic Diversion Procedure
  • Have multiple bariatric procedures coded on the same day
  • Have a diagnosis related to GI cancer occurring on day of surgery or during index hospitalization (Diagnosis determined using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)
  • Emergency department visit on the same day as hospitalization for bariatric procedure
  • Eligible patients must have uncontrolled or medication-controlled diabetes at the time of surgery.
  • Hemoglobin A1c (HbA1c) ≥6.5 % at the most recent measurement prior to surgery, or
  • Current prescription for diabetes medication at the time of surgery with the most recent HbA1c \<6.5% Patients taking only metformin will be excluded unless they also have an ICD-9-CM code for Diabetes (250.x) or have HbA1c \>=6.5% in the year prior to surgery. This includes patients with polycystic ovarian syndrome (PCOS).
  • Eligible patients must be linked to relevant data sources:
  • State or national death index (mortality outcomes);
  • Payer data/insurance claims (for Adverse Events outcomes)
  • Patients must be aged 20 through 79 years of age at time of surgery.
  • Exclude any patient with \>=365 inpatient hospitalization days in the year prior to surgery.
  • Exclude any patient without male or female sex indicated in the study data
  • Race and ethnicity available in study data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Toh S, Rasmussen-Torvik LJ, Harmata EE, Pardee R, Saizan R, Malanga E, Sturtevant JL, Horgan CE, Anau J, Janning CD, Wellman RD, Coley RY, Cook AJ, Courcoulas AP, Coleman KJ, Williams NA, McTigue KM, Arterburn D, McClay J; PCORnet Bariatric Surgery Collaborative. The National Patient-Centered Clinical Research Network (PCORnet) Bariatric Study Cohort: Rationale, Methods, and Baseline Characteristics. JMIR Res Protoc. 2017 Dec 5;6(12):e222. doi: 10.2196/resprot.8323.

    PMID: 29208590BACKGROUND
  • McTigue KM, Wellman R, Nauman E, Anau J, Coley RY, Odor A, Tice J, Coleman KJ, Courcoulas A, Pardee RE, Toh S, Janning CD, Williams N, Cook A, Sturtevant JL, Horgan C, Arterburn D; PCORnet Bariatric Study Collaborative. Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study. JAMA Surg. 2020 May 1;155(5):e200087. doi: 10.1001/jamasurg.2020.0087. Epub 2020 May 20.

  • Courcoulas A, Coley RY, Clark JM, McBride CL, Cirelli E, McTigue K, Arterburn D, Coleman KJ, Wellman R, Anau J, Toh S, Janning CD, Cook AJ, Williams N, Sturtevant JL, Horgan C, Tavakkoli A; PCORnet Bariatric Study Collaborative. Interventions and Operations 5 Years After Bariatric Surgery in a Cohort From the US National Patient-Centered Clinical Research Network Bariatric Study. JAMA Surg. 2020 Mar 1;155(3):194-204. doi: 10.1001/jamasurg.2019.5470.

  • Arterburn D, Wellman R, Emiliano A, Smith SR, Odegaard AO, Murali S, Williams N, Coleman KJ, Courcoulas A, Coley RY, Anau J, Pardee R, Toh S, Janning C, Cook A, Sturtevant J, Horgan C, McTigue KM; PCORnet Bariatric Study Collaborative. Comparative Effectiveness and Safety of Bariatric Procedures for Weight Loss: A PCORnet Cohort Study. Ann Intern Med. 2018 Dec 4;169(11):741-750. doi: 10.7326/M17-2786. Epub 2018 Oct 30.

  • Inge TH, Coley RY, Bazzano LA, Xanthakos SA, McTigue K, Arterburn D, Williams N, Wellman R, Coleman KJ, Courcoulas A, Desai NK, Anau J, Pardee R, Toh S, Janning C, Cook A, Sturtevant J, Horgan C, Zebrick AJ, Michalsky M; PCORnet Bariatric Study Collaborative. Comparative effectiveness of bariatric procedures among adolescents: the PCORnet bariatric study. Surg Obes Relat Dis. 2018 Sep;14(9):1374-1386. doi: 10.1016/j.soard.2018.04.002. Epub 2018 Apr 17.

  • Coughlin JW, Nauman E, Wellman R, Coley RY, McTigue KM, Coleman KJ, Jones DB, Lewis KH, Tobin JN, Wee CC, Fitzpatrick SL, Desai JR, Murali S, Morrow EH, Rogers AM, Wood GC, Schlundt DG, Apovian CM, Duke MC, McClay JC, Soans R, Nemr R, Williams N, Courcoulas A, Holmes JH, Anau J, Toh S, Sturtevant JL, Horgan CE, Cook AJ, Arterburn DE; PCORnet Bariatric Study Collaborative. Preoperative Depression Status and 5 Year Metabolic and Bariatric Surgery Outcomes in the PCORnet Bariatric Study Cohort. Ann Surg. 2023 Apr 1;277(4):637-646. doi: 10.1097/SLA.0000000000005364. Epub 2022 Jan 19.

  • Coleman KJ, Wellman R, Fitzpatrick SL, Conroy MB, Hlavin C, Lewis KH, Coley RY, McTigue KM, Tobin JN, McBride CL, Desai JR, Clark JM, Toh S, Sturtevant JL, Horgan CE, Duke MC, Williams N, Anau J, Horberg MA, Michalsky MP, Cook AJ, Arterburn DE, Apovian CM; PCORnet Bariatric Study Collaborative. Comparative Safety and Effectiveness of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Weight Loss and Type 2 Diabetes Across Race and Ethnicity in the PCORnet Bariatric Study Cohort. JAMA Surg. 2022 Oct 1;157(10):897-906. doi: 10.1001/jamasurg.2022.3714.

Related Links

MeSH Terms

Conditions

ObesityBody WeightDiabetes MellitusWeight Loss

Interventions

Gastric BypassHealth Records, Personal

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesEndocrine System DiseasesBody Weight Changes

Intervention Hierarchy (Ancestors)

Bariatric SurgeryBariatricsObesity ManagementTherapeuticsGastroenterostomyAnastomosis, SurgicalSurgical Procedures, OperativeDigestive System Surgical ProceduresMedical RecordsRecordsData CollectionEpidemiologic MethodsInvestigative Techniques

Study Officials

  • David E. Arterburn, MD, MPH

    Kaiser Permanente

    PRINCIPAL INVESTIGATOR
  • Kathleen M. McTigue, MD, MS, MPH

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR
  • Neely A. Williams, M.Div

    Mid-South CDRN

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 11, 2016

First Posted

April 18, 2016

Study Start

February 1, 2016

Primary Completion

April 30, 2018

Study Completion

April 30, 2018

Last Updated

December 21, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share